Nav: Home

Urine screening test may one day predict coronary artery disease

April 29, 2009

Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.

Coronary angiography, an X-ray examination of the blood vessels or chambers of the heart, is the traditional way to diagnose atherosclerosis. To perform this procedure, clinicians insert a small tube, or catheter, into a blood vessel in the groin area or arm and thread the catheter to the coronary arteries of the heart.

"Atherosclerotic disease results in heart attack and stroke, which have major impacts on life and health in the Western world," said Constantin von zur Muehlen, M.D., the study's lead author and cardiologist at the University Hospital Freiburg, Department of Cardiology in Freiburg, Germany. "We conducted this study to find new biomarkers for atherosclerosis and determine whether this noninvasive screening could reliably recognize this disease."

Proteome analysis shows protein patterns in body fluids, such as blood or urine, Muehlen said. Using two techniques to analyze specimens (mass spectrometry and capillary electrophoresis), scientists can simultaneously characterize thousands of proteins in one examination.

Muehlen and colleagues determined that certain protein fragments can only be found in coronary artery disease patients, and this patient group established the proteome pattern. The 17 protein fragments that the researchers identified as being associated with atherosclerotic disease were collagen fragments, known to be present on the surface of atherosclerotic plaques.

The researchers then applied the proteome pattern in another group of patients with atherosclerotic disease of the coronary arteries. The investigators compared the results of the urine proteome screenings from 67 patients presenting with symptoms of coronary artery disease to patients' results from coronary angiography, the current gold standard used to rule out or confirm coronary artery disease.

"The accuracy of the urine proteome pattern to identify coronary artery disease was 84 percent," Muehlen said.

Larger studies will be needed to confirm the findings of this study before proteome analysis can be used as a reliable screening method in patients, Muehlen said. "However, our data suggest that proteome analysis shows great promise. It is easy to use, shows a high reproducibility and does not hurt."
-end-
Co-authors are: Eric Schiffer, Ph.D.; Petra Zuerbig, Ph.D.; Harald Mischak, Ph.D.; Christoph Bode, M.D.; and Karlheinz Peter, M.D., Ph.D. Individual author disclosures can be found on the abstract.

Mosaiques Diagnostics & Therapeutics AG, based in Hannover, Germany, co-funded the study and is the maker of the test.

(Note: Presentation is 5:30 p.m. ET, Wednesday, April 29, 2009)

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.

American Heart Association

Related Atherosclerosis Articles:

Atherosclerosis -- How a microRNA protects vascular integrity
Ludwig-Maximilian-Universitaet (LMU) in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.
Atherosclerosis progresses rapidly in healthy people from the age of 40
A CNIC study published in JACC demonstrates that atheroma plaques extend rapidly in the arteries of asymptomatic individuals aged between 40 and 50 years participating in the PESA-CNIC-Santander study.
Discovery may illuminate a missing link between atherosclerosis and aging
Using a preclinical model of atherosclerosis, Feinberg and colleagues have uncovered a long, noncoding RNA (lncRNA) that may point the way toward new therapies for atherosclerosis and shed light on why the likelihood of the disease increases with age.
Scaling up a nanoimmunotherapy for atherosclerosis through preclinical testing
By integrating translational imaging techniques with improvements to production methods, Tina Binderup and colleagues have scaled up a promising nanoimmunotherapy for atherosclerosis in mice, rabbits and pigs -- surmounting a major obstacle in nanomedicine.
Bladder drug linked to atherosclerosis in mice
A drug used in the treatment of overactive bladder can accelerate atheroclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences (PNAS).
A new therapeutic target for blocking early atherosclerosis in progeria
Researchers at the Centro Nacional de Investigaciones Cardiovasculares and the Universidad de Oviedo have discovered a new molecular mechanism involved in the premature development of atherosclerosis in mice with Hutchinson-Gilford progeria syndrome.
Protective mechanism against atherosclerosis discovered
Immune cells promoting inflammation play a crucial role in the development of atherosclerosis.
Atherosclerosis: Stopped on time
For the first time, LMU researchers are pointing out the influence of the internal clock on atherosclerosis.
New actors identified in atherosclerosis
Stroke and heart attack are the leading cause of death in the Western world.
Running multiple marathons does not increase risk of atherosclerosis
Running multiple marathons does not increase the risk of atherosclerosis, according to research published today in the European Journal of Preventive Cardiology.
More Atherosclerosis News and Atherosclerosis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.